Citadel Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-26,400
| Closed | -$2.45M | – | 15208 |
|
|
2021
Q4 | $2.45M | Sell |
26,400
-12,100
| -31% | -$797K | ﹤0.01% | 5774 |
|
|
2021
Q3 | $2.29M | Buy |
38,500
+7,600
| +25% | +$449K | ﹤0.01% | 6008 |
|
|
2021
Q2 | $2.11M | Sell |
30,900
-11,900
| -28% | -$776K | ﹤0.01% | 6491 |
|
|
2021
Q1 | $2.97M | Buy |
42,800
+11,100
| +35% | +$854K | ﹤0.01% | 5469 |
|
|
2020
Q4 | $2.44M | Sell |
31,700
-16,000
| -34% | -$1.2M | ﹤0.01% | 4948 |
|
|
2020
Q3 | $3.57M | Buy |
47,700
+2,300
| +5% | +$153K | ﹤0.01% | 3680 |
|
|
2020
Q2 | $2.86M | Sell |
45,400
-4,700
| -9% | -$259K | ﹤0.01% | 3946 |
|
|
2020
Q1 | $2.1M | Buy |
50,100
+5,100
| +11% | +$234K | ﹤0.01% | 4065 |
|
|
2019
Q4 | $2.04M | Buy |
45,000
+11,900
| +36% | +$563K | ﹤0.01% | 4384 |
|
|
2019
Q3 | $1.51M | Sell |
33,100
-5,000
| -13% | -$281K | ﹤0.01% | 4910 |
|
|
2019
Q2 | $2.23M | Sell |
38,100
-10,700
| -22% | -$553K | ﹤0.01% | 4324 |
|
|
2019
Q1 | $2.19M | Sell |
48,800
-53,600
| -52% | -$2.46M | ﹤0.01% | 4310 |
|
|
2018
Q4 | $3.99M | Buy |
102,400
+16,200
| +19% | +$636K | ﹤0.01% | 3111 |
|
|
2018
Q3 | $3.97M | Buy |
86,200
+33,100
| +62% | +$1.34M | ﹤0.01% | 3311 |
|
|
2018
Q2 | $2.31M | Sell |
53,100
-39,200
| -42% | -$1.68M | ﹤0.01% | 3887 |
|
|
2018
Q1 | $3.65M | Buy |
92,300
+71,400
| +342% | +$2.78M | ﹤0.01% | 2858 |
|
|
2017
Q4 | $710K | Sell |
20,900
-9,700
| -32% | -$276K | ﹤0.01% | 5142 |
|
|
2017
Q3 | $780K | Buy |
+30,600
| New | +$702K | ﹤0.01% | 4669 |
|
|
2017
Q2 | – | Sell |
-4,050
| Closed | -$59K | – | 8281 |
|
|
2017
Q1 | $59K | Sell |
4,050
-3,000
| -43% | -$44.4K | ﹤0.01% | 7011 |
|
|
2016
Q4 | $100K | Sell |
7,050
-1,570
| -18% | -$24.3K | ﹤0.01% | 6677 |
|
|
2016
Q3 | $151K | Sell |
8,620
-440
| -5% | -$7.3K | ﹤0.01% | 6465 |
|
|
2016
Q2 | $155K | Buy |
9,060
+1,230
| +16% | +$22K | ﹤0.01% | 6007 |
|
|
2016
Q1 | $154K | Buy |
7,830
+2,550
| +48% | +$40.9K | ﹤0.01% | 5814 |
|
|
2015
Q4 | $100K | Buy |
5,280
+1,590
| +43% | +$32.4K | ﹤0.01% | 6692 |
|
|
2015
Q3 | $70K | Sell |
3,690
-3,860
| -51% | -$131K | ﹤0.01% | 7306 |
|
|
2015
Q2 | $350K | Buy |
7,550
+1,960
| +35% | +$85K | ﹤0.01% | 5523 |
|
|
2015
Q1 | $244K | Sell |
5,590
-16,420
| -75% | -$763K | ﹤0.01% | 5932 |
|
|
2014
Q4 | $764K | Buy |
22,010
+15,720
| +250% | +$638K | ﹤0.01% | 4125 |
|
|
2014
Q3 | $264K | Sell |
6,290
-2,440
| -28% | -$109K | ﹤0.01% | 5423 |
|
|
2014
Q2 | $512K | Sell |
8,730
-6,500
| -43% | -$409K | ﹤0.01% | 4351 |
|
|
2014
Q1 | $959K | Sell |
15,230
-10,460
| -41% | -$694K | ﹤0.01% | 3483 |
|
|
2013
Q4 | $1.5M | Buy |
25,690
+1,190
| +5% | +$62.2K | ﹤0.01% | 2818 |
|
|
2013
Q3 | $1.29M | Sell |
24,500
-17,740
| -42% | -$1.19M | ﹤0.01% | 2837 |
|
|
2013
Q2 | $3.25M | Buy |
+42,240
| New | +$3.45M | 0.01% | 1984 |
|
Citadel Advisors's ARNA Position: Q1 2022 in Review
Citadel Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 337,629 shares — an estimated $31.4M sold.
Citadel Advisors first reported a position in ARNA in Q2 2013 and held it in 32 quarters. The position peaked at $63.6M in Q2 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Citadel Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Citadel Advisors sold 337,629 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $31.4M.
- Citadel Advisors first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 32 quarters.
- Citadel Advisors's Arena Pharmaceuticals Inc position peaked at $63.6M in Q2 2020.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.